Navigation Links
Laureate Pharma Appoints Gary Swan as Vice President of Operations
Date:2/14/2008

- Augments Senior Management Team with more than 30 Years Experience in

Biopharmaceutical Manufacturing, Engineering, Technical Services and

Validation -

PRINCETON, N.J., Feb. 14 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the appointment of Gary Swan as Vice President of Operations. In this newly created position, Mr. Swan will be responsible for leading Laureate's manufacturing operations, which include upstream processing, downstream processing, formulation and filling, facilities maintenance, warehouse operations, and environmental, health and safety regulations.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )

"We are delighted to welcome Gary to Laureate's senior leadership team," said Robert J. Broeze, Ph.D., President and CEO of Laureate. "With his strong background and extensive experience of more than 30 years in biopharmaceutical manufacturing operations, Gary will play a key leadership role in driving and managing Laureate's tremendous growth."

Gary's experience includes biopharmaceutical manufacturing, engineering, technical services, validation, and quality control. Most recently, Gary held the position of Senior Director of Manufacturing at Nastech Pharmaceuticals in Hauppauge, NY, a publicly traded biopharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. At Nastech, Gary directed the operations at two manufacturing sites in New York and Washington. In this capacity, he also led the planning and scheduling of the production of R&D, clinical, and licensed products. Prior to Nastech, Gary was the Vice President of Operations at VI Technologies in Melville, NY, a publicly traded biopharmaceutical company with a focus on development and manufacturing of virus-inactivated blood products and the purification of proteins from blood components. At VI, Gary was responsible for strategic planning and daily operation of a 100,000 SF sterile product biopharmaceutical facility with a staff of 200. Gary has a BS in Biology from Auburn University, Auburn, AL.

About Laureate Pharma, Inc.

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. Laureate Pharma, Inc. is a partner company of Safeguard Scientifics, Inc. (NYSE: SFE; http://www.safeguard.com), which provides growth capital for entrepreneurial and innovative technology and life sciences companies through expansion financings, corporate spin-outs, management buyouts, recapitalizations, industry consolidations and early-stage financings. For more information, contact Michael Cavanaugh, Vice President Sales, Marketing, and Business Development at (609) 919-3400 or info@laureatepharma.com, or visit http://www.laureatepharma.com.


'/>"/>
SOURCE Laureate Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
2. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
3. American Scientists Named as Laureates of the 2008 (24th) Japan Prize
4. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
5. Pharmaxis to Apply to Market Bronchitol in Australia
6. Marketing and Meeting Details (M2D) Offers Customized Convention Registration and Management Tool to Clients Inside and Outside of Pharma/Biotech
7. Vion Pharmaceuticals Holds Special Meeting of Stockholders
8. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
9. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
10. Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
11. Nastech Pharmaceutical Company Implements Additional Workforce Reduction as Part of Previously Announced Corporate Restructuring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... -- Cousins Properties (NYSE: CUZ ) announced today ... signed a 10-year, approximately 125,000 square-foot lease at Corporate Center, ... the Westshore submarket of Tampa, FL. ... Corporate Center for their new location in Tampa ... executive officer of Cousins Properties. "Amgen is a cutting-edge global ...
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture Fund (MBVF), ... the standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 is ... ) and the US National Institutes of Health. ... ... ...
(Date:3/27/2017)... , March 27, 2017  Perthera,s Chief Bioinformatics Officer ... Subha Madhavan , Ph.D., will be speaking at ... Panels. On Monday, March 27, 2017, she will be ... More Usable for Research and Care" (from 10:30 a.m. ... 2017, she will be a participant in the "Making ...
(Date:3/27/2017)... ... ... PMG Research is pleased to announce its participation in the 2nd ... Boston on April 3-4, 2017. The CTC conference focuses on how the industry is ... closer to the patient. Clinical Trial Collaborations also will present an inaugural conference on ...
Breaking Biology Technology:
(Date:2/14/2017)... WINSTON-SALEM, N.C. , Feb. 14, 2017  Wake ... FRY-shlog), M.D., as its new chief executive officer (CEO). ... succeeds CEO John D. McConnell , M.D., who ... new position at the Medical Center, after leading it ... oversee the full scope of Wake Forest Baptist,s academic ...
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
(Date:2/9/2017)... 2017 The biomass boiler market report by ... boiler market globally in terms of revenue (US$ Mn) ... market for biomass boilers has been segmented on the ... country/region. The market based on feedstock type, has been ... & energy crops, urban residues, and others. On the ...
Breaking Biology News(10 mins):